<DOC>
	<DOCNO>NCT00153491</DOCNO>
	<brief_summary>This study well caregiver child malaria adhere recommend regimen lumefantrine-artemether ( LA ) . Children randomly assign either group receive directly observe treatment hospital group treat home routine caregiver ( typically , patient 's mother ) . Clinical/parasitologic , hematologic , pharmacologic qualitative parameter monitor 28-day follow-up period use evaluate drug adherence .</brief_summary>
	<brief_title>Adherence Lumefantrine-Artemether</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<criteria>Inclusion criterion : age &lt; 5 year age . axillary temperature &gt; = 37.5oC unmixed infection P. falciparum 1,000 250,000 asexual parasites/mm3 determine microscopic examination thick , thick thin peripheral blood smear . parent/guardian 's informed consent willingness participate study Exclusion criterion : evidence severe complicate malaria would require hospitalization treatment . report allergy antimalarial drug , include artemisinin derivative sulfa drug .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>malaria</keyword>
	<keyword>artemether-lumefantrine</keyword>
	<keyword>co-artem</keyword>
	<keyword>Tanzania</keyword>
	<keyword>adherence</keyword>
</DOC>